XML 44 R31.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Product Information [Line Items]          
Proceeds from sale of investment     $ 1,800    
Loss on sale of investment     515    
Stock-based compensation $ 300 $ 488 1,279 $ 1,243  
Unrecognized stock-based compensation expense $ 5,952   $ 5,952    
Weighted-average remaining vesting period     2 years 2 months 12 days    
Effective tax rate 0.00% 0.00% 1.00% 4.00%  
Restricted Stock Units (RSUs) [Member]          
Product Information [Line Items]          
Option Forfeited     450    
Option Forfeited     $ 450    
Weighted Average Grant     $ 473,000    
Weighted average grant-date fair value     5.86    
R S As [Member]          
Product Information [Line Items]          
Weighted Average Grant     324,401    
Weighted average grant-date fair value     5.56    
Non Qualified Stock Options [Member]          
Product Information [Line Items]          
Weighted Average Grant     393,750    
Weighted average grant-date fair value     $ 1.79    
Measurement Input, Risk Free Interest Rate [Member] | Black Scholes Method [Member] | Restricted Stock Units [Member]          
Product Information [Line Items]          
Assumptions used for derivatives     1.38 percent    
Measurement Input, Expected Term [Member] | Black Scholes Method [Member] | Restricted Stock Units [Member]          
Product Information [Line Items]          
Assumptions used for derivatives     3.00 years    
Measurement Input, Price Volatility [Member] | Black Scholes Method [Member] | Restricted Stock Units [Member]          
Product Information [Line Items]          
Assumptions used for derivatives     38 percent    
Measurement Input, Expected Dividend Rate [Member] | Black Scholes Method [Member] | Restricted Stock Units [Member]          
Product Information [Line Items]          
Assumptions used for derivatives     0 percent    
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Licensee [Member]          
Product Information [Line Items]          
Concentration risk percentage 32.00% 98.00% 50.00%    
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Licensee [Member]          
Product Information [Line Items]          
Concentration risk percentage 25.00%   19.00% 9.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Three Licensee [Member]          
Product Information [Line Items]          
Concentration risk percentage 22.00%   12.00%    
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Licensee 2 [Member]          
Product Information [Line Items]          
Concentration risk percentage 13.00%        
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Licensee 3 [Member]          
Product Information [Line Items]          
Concentration risk percentage       75.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Foreign Licensee [Member]          
Product Information [Line Items]          
Concentration risk percentage 8.00% 0.10% 15.00% 5.00%  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Licensee [Member]          
Product Information [Line Items]          
Concentration risk percentage     100.00%   62.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Licensee [Member]          
Product Information [Line Items]          
Concentration risk percentage     100.00%    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Licensee 2 [Member]          
Product Information [Line Items]          
Concentration risk percentage         21.00%